+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Lewy Body Dementia Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Type; By Indication [Parkinson's Disease and Dementia with Lewy Bodies]; By Distribution Channel; By Regions Segment Forecast, 2020 - 2027

  • ID: 5261955
  • Report
  • December 2020
  • Region: Global
  • 112 Pages
  • Polaris Market Research

FEATURED COMPANIES

  • Allergan Plc.
  • BioArctic AB
  • Eisai Co. Ltd.
  • GlaxoSmithKline
  • Mylan NV.
  • Pfizer Inc.
The global Lewy body dementia treatment market size is predicted to reach USD 5.31 billion by 2027 according to this new study. The report “Lewy Body Dementia Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Modafinil, Cholinesterase Inhibitors, Benzodiazepine, Antipsychotic Drugs, Anti-depressants, and Carbidopa-Levodopa); By Indication [Parkinson’s Disease and Dementia with Lewy Bodies (DLB)]; By Distribution Channel; By Regions Segment Forecast, 2020-2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.







Lewy body dementia is a progressive disorder associated with dysfunction of the central nervous system and characterized by deposits of alpha-synuclein, a protein in the brain. The unusual deposits in the brain formed Lewy bodies, which can lead to several problems with body movement, thinking, mood, and behavior. Lewy body dementia is the most common disease after Alzheimer’s which is rapidly growing and subsequently foster global market growth. Recent developments include the new launches and clinical studies such as LY3154207, ABBV-0805, etc. The launches of drugs are associated with the diagnosis of dementia with Lewy body, Parkinson’s, and Alzheimer’s diseases which further leads to drive the growth of the global market.

The prominent factors favoring the global market growth include the rising initiatives by the legal and regulatory authorities to develop an effective and safe treatment for the LBD disorder in the patients. For instance, in October 2019, an LBD Association Research Center of Excellence, Georgetown University Medical Center, has taken the initiative to offer 3 clinical trials to devise new methods and treatments for Lewy body dementia and Alzheimer’s disease.

Rising incidences of getting affected by Alzheimer’s disease and related disorders include vascular dementia, Lewy body dementia, frontotemporal degeneration, and Parkinson’s disease has witnessed the surge in demand for the treatment of the patients. The regulatory authorities and researchers are engaged in discovering new methods and solutions to provide effective treatment of the disorder.

For instance, in June 2020, The Harry T. Mangurian, Jr. Foundation and Florida Atlantic University’s Schmidt College of Medicine have amalgamated its forces to discover and research medicine to prevent dementia. The grant of USD 3 million will allow FAU’s Schmidt College of Medicine to establish a new FAU Center for Brain Health. Furthermore, in July 2020, the Journal of the American Medical Association (JAMA) has published that researchers have formed a new p-tau217 blood test, which is proved to hold remarkable results in the diagnosis of Alzheimer’s disease and related disorders in the patients.

Additionally, the rising prevalence of the progressive diseases of dementia has raised the need for effective treatment to treat the disease and prevent risk in the patients which further leads to drive growth. The growing awareness of the symptoms of the disease and the advancement in healthcare technology to develop new methods and drugs for the treatment of patients is likely to surge the market growth.

Market participants such as Mallinckrodt Pharmaceuticals, BioArctic AB, Bausch Health Companies Inc., Sumitomo Dainippon Pharma Co., Ltd., Janssen Pharmaceuticals, Inc., Jazz Pharmaceuticals, Inc., Allergan Plc., Noven Pharmaceuticals, Inc., Takeda Pharmaceutical Company Ltd., Eli Lilly and Company, Eisai Co., Ltd., Novartis AG, GlaxoSmithKline, Pfizer Inc., Teva Pharmaceuticals, Bayer AG, Sanofi AG, and Mylan NV are some of the key players operating in the industry.

Players in the industry are focusing on developing new methods and drugs for LBD, new launches, increasing expansions, collaborations, and partnerships to enhance their market and revenue share. For instance, in August 2020, Proteostasis Therapeutics, Inc. and Yumanity Therapeutics entered into a definitive merger agreement, and after combining they operate under the name Yumanity Therapeutics, Inc. The merger leads to enhance Yumanity’s pipeline of innovative, disease-modifying methods and solutions for neurological disorders.

The publisher has segmented the Lewy Body Dementia Treatment market report on the basis of drug type, indication, distribution channel, and region

Lewy Body Dementia Treatment Market By Drug Type (Revenue-USD Million, 2016-2027)


Modafinil
Cholinesterase Inhibitors
Benzodiazepine
Antipsychotic Drugs
Antidepressants
Carbidopa-Levodopa

Lewy Body Dementia Treatment Market By Indication (Revenue-USD Million, 2016-2027)


Parkinson’s Disease

Dementia with Lewy Bodies (DLB)

Lewy Body Dementia Treatment Market By Distribution Channel (Revenue-USD Million, 2016-2027)


Drug Stores
Hospitals Pharmacies
Online Pharmacies
Retail Pharmacies

Lewy Body Dementia Treatment Market By Regional Outlook (Revenue-USD Million, 2016-2027)


North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Spain
Netherlands
Austria
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Central & South America
Mexico
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Frequently Asked Questions about the Lewy Body Dementia Treatment Market

What is the estimated value of the Lewy Body Dementia Treatment Market?

The Lewy Body Dementia Treatment Market was estimated to be valued at $3597.9 Million in 2020.

What is the growth rate of the Lewy Body Dementia Treatment Market?

The growth rate of the Lewy Body Dementia Treatment Market is 5.1%, with an estimated value of $5310.0 Million by 2027.

What is the forecasted size of the Lewy Body Dementia Treatment Market?

The Lewy Body Dementia Treatment Market is estimated to be worth $5310.0 Million by 2027.

Who are the key companies in the Lewy Body Dementia Treatment Market?

Key companies in the Lewy Body Dementia Treatment Market include Mallinckrodt Pharmaceuticals, BioArctic AB, Bausch Health Companies Inc., Sumitomo Dainippon Pharma Co. Ltd., Janssen Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Allergan Plc., Noven Pharmaceuticals Inc. and Eli Lilly.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allergan Plc.
  • BioArctic AB
  • Eisai Co. Ltd.
  • GlaxoSmithKline
  • Mylan NV.
  • Pfizer Inc.
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary
2.1. Market Highlights

3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources

4. Lewy Body Dementia Treatment Market Insights
4.1. Lewy Body Dementia Treatment - Industry snapshot
4.2. Lewy Body Dementia Treatment Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Prevalence of Lewy body dementia
4.2.1.2. Affordable Treatment Options
4.2.2. Restraints and Challenges
4.2.2.1. Drug side-effects
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Lewy Body Dementia Treatment Market Industry trends

5. Lewy Body Dementia Treatment Market Assessment by Drug Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
5.3. Modafinil
5.3.1. Global Lewy Body Dementia Treatment Market, by Modafinil, by Region, 2016 - 2027 (USD Million)
5.4. Cholinesterase Inhibitors
5.4.1. Global Lewy Body Dementia Treatment Market, by Cholinesterase Inhibitors, by Region, 2016 - 2027 (USD Million)
5.5. Benzodiazepine
5.5.1. Global Lewy Body Dementia Treatment Market, by Benzodiazepine, by Region, 2016 - 2027 (USD Million)
5.6. Antipsychotic Drugs
5.6.1. Global Lewy Body Dementia Treatment Market, by Antipsychotic Drugs, by Region, 2016 - 2027 (USD Million)
5.7. Antidepressants
5.7.1. Global Lewy Body Dementia Treatment Market, by Antidepressants, by Region, 2016 - 2027 (USD Million)
5.8. Carbidopa-Levodopa
5.8.1. Global Lewy Body Dementia Treatment Market, by Carbidopa-Levodopa, by Region, 2016 - 2027 (USD Million)

6. Lewy Body Dementia Treatment Market Assessment by Indication
6.1. Key Findings
6.2. Introduction
6.2.1. Global Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
6.3. Parkinson’s Disease
6.3.1. Global Lewy Body Dementia Treatment Market, by Parkinson’s Disease, By Region, 2016 - 2027 (USD Million)
6.4. Dementia with Lewy Bodies (DLB)
6.4.1. Global Lewy Body Dementia Treatment Market, by Dementia with Lewy Bodies (DLB), by Region, 2016 - 2027 (USD Million)

7. Lewy Body Dementia Treatment Market Assessment by Distribution Channel
7.1. Key Findings
7.2. Introduction
7.2.1. Global Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
7.3. Drug Stores
7.3.1. Global Lewy Body Dementia Treatment Market, by Drug Stores, by Region, 2016 - 2027 (USD Million)
7.4. Hospitals Pharmacies
7.4.1. Global Lewy Body Dementia Treatment Market, by Hospitals Pharmacies, by Region, 2016 - 2027 (USD Million)
7.5. Online Pharmacies
7.5.1. Global Lewy Body Dementia Treatment Market, by Online Pharmacies, by Region, 2016 - 2027 (USD Million)
7.6. Retail Pharmacies
7.6.1. Global Lewy Body Dementia Treatment Market, by Retail Pharmacies, by Region, 2016 - 2027 (USD Million)

8. Lewy Body Dementia Treatment Market Assessment by Geography
8.1. Key findings
8.2. Introduction
8.2.1. Lewy Body Dementia Treatment Market Assessment, By Geography, 2016 - 2027 (USD Million)
8.3. Lewy Body Dementia Treatment Market - North America
8.3.1. North America: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.3.2. North America: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.3.3. North America: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.3.4. Lewy Body Dementia Treatment Market - U. S.
8.3.4.1. U. S: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.3.4.2. U. S: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.3.4.3. U. S: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.3.5. Lewy Body Dementia Treatment Market - Canada
8.3.5.1. Canada: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.3.5.2. Canada: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.3.5.3. Canada: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.4. Lewy Body Dementia Treatment Market - Europe
8.4.1. Europe: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.4.2. Europe: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.4.3. Europe: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.4.4. Lewy Body Dementia Treatment Market - UK
8.4.4.1. UK: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.4.4.2. UK: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.4.4.3. UK: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.4.5. Lewy Body Dementia Treatment Market - France
8.4.5.1. France: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.4.5.2. France: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.4.5.3. France: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.4.6. Lewy Body Dementia Treatment Market - Germany
8.4.6.1. Germany: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.4.6.2. Germany: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.4.6.3. Germany: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.4.7. Lewy Body Dementia Treatment Market - Italy
8.4.7.1. Italy: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.4.7.2. Italy: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.4.7.3. Italy: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.4.8. Lewy Body Dementia Treatment Market - Spain
8.4.8.1. Spain: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.4.8.2. Spain: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.4.8.3. Spain: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.4.9. Lewy Body Dementia Treatment Market - Netherlands
8.4.9.1. Netherlands: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.4.9.2. Netherlands: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.4.9.3. Netherlands: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.4.10. Lewy Body Dementia Treatment Market - Austria
8.4.10.1. Austria: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.4.10.2. Austria: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.4.10.3. Austria: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.5. Lewy Body Dementia Treatment Market - Asia-Pacific
8.5.1. Asia Pacific: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.5.2. Asia Pacific: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.5.3. Asia Pacific: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.5.4. Lewy Body Dementia Treatment Market - China
8.5.4.1. China: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.5.4.2. China: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.5.4.3. China: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.5.5. Lewy Body Dementia Treatment Market - India
8.5.5.1. India: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.5.5.2. India: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.5.5.3. India: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.5.6. Lewy Body Dementia Treatment Market - Malaysia
8.5.6.1. Malaysia: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.5.6.2. Malaysia: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.5.6.3. Malaysia: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.5.7. Lewy Body Dementia Treatment Market - Japan
8.5.7.1. Japan: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.5.7.2. Japan: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.5.7.3. Japan: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.5.8. Lewy Body Dementia Treatment Market - Indonesia
8.5.8.1. Indonesia: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.5.8.2. Indonesia: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.5.8.3. Indonesia: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.5.9. Lewy Body Dementia Treatment Market - South Korea
8.5.9.1. South Korea: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.5.9.2. South Korea: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.5.9.3. South Korea: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.6. Lewy Body Dementia Treatment Market - Middle East & Africa
8.6.1. Middle East & Africa: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.6.2. Middle East & Africa: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.6.3. Middle East & Africa: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.6.4. Lewy Body Dementia Treatment Market - Saudi Arabia
8.6.4.1. Saudi Arabia: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.6.4.2. Saudi Arabia: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.6.4.3. Saudi Arabia: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.6.5. Lewy Body Dementia Treatment Market - UAE
8.6.5.1. UAE: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.6.5.2. UAE: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.6.5.3. UAE: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.6.6. Lewy Body Dementia Treatment Market - Israel
8.6.6.1. Israel: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.6.6.2. Israel: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.6.6.3. Israel: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.6.7. Lewy Body Dementia Treatment Market - South Africa
8.6.7.1. South Africa: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.6.7.2. South Africa: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.6.7.3. South Africa: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.7. Lewy Body Dementia Treatment Market - Latin America
8.7.1. Latin America: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.7.2. Latin America: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.7.3. Latin America: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.7.4. Lewy Body Dementia Treatment Market - Mexico
8.7.4.1. Mexico: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.7.4.2. Mexico: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.7.4.3. Mexico: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.7.5. Lewy Body Dementia Treatment Market - Brazil
8.7.5.1. Brazil: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.7.5.2. Brazil: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.7.5.3. Brazil: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
8.7.6. Lewy Body Dementia Treatment Market - Argentina
8.7.6.1. Argentina: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
8.7.6.2. Argentina: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
8.7.6.3. Argentina: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)

9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles
10.1. Axovant Sciences Ltd.
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Drug Type/Indication Benchmarking
10.1.4. Recent Development
10.2. BioArctic AB
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Drug Type/Indication Benchmarking
10.2.4. Recent Development
10.2.5. RealView Imaging Ltd.
10.3. Eisai Co., Ltd.
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Drug Type/Indication Benchmarking
10.3.4. Recent Development
10.3.5. Nanolive SA
10.4. Sumitomo Dainippon Pharma Co., Ltd.
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Drug Type/Indication Benchmarking
10.4.4. Recent Development
10.5. Jazz Pharmaceuticals, Inc.
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Drug Type/Indication Benchmarking
10.5.4. Recent Development
10.6. Immungenetics AG
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Drug Type/Indication Benchmarking
10.6.4. Recent Development
10.7. Noven Pharmaceuticals, Inc.
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Drug Type/Indication Benchmarking
10.7.4. Recent Development
10.8. Teva Pharmaceutical Industries Limited
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Drug Type/Indication Benchmarking
10.8.4. Recent Development

List of Tables
Table 1. Global Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 2. Global Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 3. Global Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
Table 4. Lewy Body Dementia Treatment Market Assessment, By Geography, 2016 - 2027 (USD Million)
Table 5. North America: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 6. North America: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 7. North America: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 8. U.S.: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 9. U.S.: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 10. U.S.: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 11. Canada: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 12. Canada: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 13. Canada: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 14. Europe: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 15. Europe: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 16. Europe: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 17. UK: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 18. UK: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 19. UK: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 20. France: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 21. France: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 22. France: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 23. Germany: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 24. Germany: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 25. Germany: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 26. Italy: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 27. Italy: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 28. Italy: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 29. Spain: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 30. Spain: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 31. Spain: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 32. Netherlands: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 33. Netherlands: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 34. Netherlands: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 35. Austria: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 36. Austria: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 37. Austria: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 38. Asia Pacific: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 39. Asia Pacific: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 40. Asia Pacific: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 41. China: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 42. China: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 43. China: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 44. India: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 45. India: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 46. India: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 47. Malaysia: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 48. Malaysia: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 49. Malaysia: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 50. Japan: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 51. Japan: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 52. Japan: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 53. Indonesia: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 54. Indonesia: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 55. Indonesia: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 56. South Korea: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 57. South Korea: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 58. South Korea: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 59. Middle East & Africa: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 60. Middle East & Africa: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 61. Middle East & Africa: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 62. Saudi Arabia: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 63. Saudi Arabia: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 64. Saudi Arabia: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 65. UAE: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 66. UAE: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 67. UAE: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 68. Israel: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 69. Israel: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 70. Israel: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 71. South Africa: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 72. South Africa: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 73. South Africa: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 74. Latin America: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 75. Latin America: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 76. Latin America: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 77. Mexico: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 78. Mexico: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 79. Mexico: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 80. Brazil: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 81. Brazil: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 82. Brazil: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
Table 83. Argentina: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
Table 84. Argentina: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
Table 85. Argentina: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)

List of Figures
Figure 1. Market Highlights (2019, Revenue)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 6. Porter’s Five Forces
Figure 7. Market by Drug Type
Figure 8. Global Lewy Body Dementia Treatment Market, By Drug Type, 2019 & 2027 (USD Million)
Figure 9. Market by Indication
Figure 10. Global Lewy Body Dementia Treatment Market, By Indication, 2019 & 2027 (USD Million)
Figure 11. Market by Distribution Channel
Figure 12. Global Lewy Body Dementia Treatment Market, By Distribution Channel, 2019 & 2027 (USD Million)
Figure 13. Lewy Body Dementia Treatment Market Assessment, By Geography, 2016 - 2027 (USD Million)
Figure 14. Strategic Analysis - Lewy Body Dementia Treatment Market
Note: Product cover images may vary from those shown
  • Mallinckrodt Pharmaceuticals
  • BioArctic AB
  • Bausch Health Companies Inc.
  • Sumitomo Dainippon Pharma Co. Ltd.
  • Janssen Pharmaceuticals Inc.
  • Jazz Pharmaceuticals Inc.
  • Allergan Plc.
  • Noven Pharmaceuticals Inc.
  • Takeda Pharmaceutical Company Ltd.
  • Eli Lilly
  • Company
  • Eisai Co. Ltd.
  • Novartis AG
  • GlaxoSmithKline
  • Pfizer Inc.
  • Teva Pharmaceuticals
  • Bayer AG
  • Sanofi AG
  • Mylan NV.
Note: Product cover images may vary from those shown